The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons

<div><p>Selenium application as sodium selenate was repeatedly shown to have anti-carcinogenic properties by increasing levels of the serine/ threonine protein phosphatase 2A (PP2A) in cancer cells. PP2A has a prominent role in cell development, homeostasis, and in neurons regulates exci...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Wesal Habbab (17346961) (author)
مؤلفون آخرون: Imad Aoudé (18174946) (author), Freshteh Palangi (4278685) (author), Sara Abdulla (8548053) (author), Tariq Ahmed (5768081) (author)
منشور في: 2019
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513520283942912
author Wesal Habbab (17346961)
author2 Imad Aoudé (18174946)
Freshteh Palangi (4278685)
Sara Abdulla (8548053)
Tariq Ahmed (5768081)
author2_role author
author
author
author
author_facet Wesal Habbab (17346961)
Imad Aoudé (18174946)
Freshteh Palangi (4278685)
Sara Abdulla (8548053)
Tariq Ahmed (5768081)
author_role author
dc.creator.none.fl_str_mv Wesal Habbab (17346961)
Imad Aoudé (18174946)
Freshteh Palangi (4278685)
Sara Abdulla (8548053)
Tariq Ahmed (5768081)
dc.date.none.fl_str_mv 2019-02-15T03:00:00Z
dc.identifier.none.fl_str_mv 10.3390/ijms20040844
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/The_Anti-Tumor_Agent_Sodium_Selenate_Decreases_Methylated_PP2A_Increases_GSK3_Y216_Phosphorylation_Including_Tau_Disease_Epitopes_and_Reduces_Neuronal_Excitability_in_SHSY-5Y_Neurons/25428316
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Chemical sciences
Analytical chemistry
Inorganic chemistry
Organic chemistry
Physical chemistry
Theoretical and computational chemistry
PP2A
GSK3β
Tau
retinoic acid differentiated SHSY-5Y cells
dc.title.none.fl_str_mv The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <div><p>Selenium application as sodium selenate was repeatedly shown to have anti-carcinogenic properties by increasing levels of the serine/ threonine protein phosphatase 2A (PP2A) in cancer cells. PP2A has a prominent role in cell development, homeostasis, and in neurons regulates excitability. PP2A, GSK3β and Tau reside together in a complex, which facilitates their interaction and (dys)-function as has been reported for several neurological disorders. In this study we recorded maximum increase in total PP2A at 3 µM sodium selenate in a neuron cell line. In conjunction with these data, whole-cell electrophysiological studies revealed that this concentration had maximum effect on membrane potentials, conductance and currents. Somewhat surprisingly, the catalytically active form, methylated PP2A (mePP2A) was significantly decreased. In close correlation to these data, the phosphorylation state of two substrate proteins, sensitive to PP2A activity, GSK3β and Tau were found to be increased. In summary, our data reveal that sodium selenate enhances PP2A levels, but reduces catalytic activity of PP2A in a dose dependent manner, which fails to reduce Tau and GSK3β phosphorylation under physiological conditions, indicating an alternative route in the rescue of cell pathology in neurological disorders.</p><p> </p></div><h2>Other Information</h2> <p> Published in: International Journal of Molecular Sciences<br> License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/ijms20040844" target="_blank">https://dx.doi.org/10.3390/ijms20040844</a></p>
eu_rights_str_mv openAccess
id Manara2_28eac97404c76133318dcf8eb1b7ecb5
identifier_str_mv 10.3390/ijms20040844
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/25428316
publishDate 2019
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y NeuronsWesal Habbab (17346961)Imad Aoudé (18174946)Freshteh Palangi (4278685)Sara Abdulla (8548053)Tariq Ahmed (5768081)Chemical sciencesAnalytical chemistryInorganic chemistryOrganic chemistryPhysical chemistryTheoretical and computational chemistryPP2AGSK3βTauretinoic acid differentiated SHSY-5Y cells<div><p>Selenium application as sodium selenate was repeatedly shown to have anti-carcinogenic properties by increasing levels of the serine/ threonine protein phosphatase 2A (PP2A) in cancer cells. PP2A has a prominent role in cell development, homeostasis, and in neurons regulates excitability. PP2A, GSK3β and Tau reside together in a complex, which facilitates their interaction and (dys)-function as has been reported for several neurological disorders. In this study we recorded maximum increase in total PP2A at 3 µM sodium selenate in a neuron cell line. In conjunction with these data, whole-cell electrophysiological studies revealed that this concentration had maximum effect on membrane potentials, conductance and currents. Somewhat surprisingly, the catalytically active form, methylated PP2A (mePP2A) was significantly decreased. In close correlation to these data, the phosphorylation state of two substrate proteins, sensitive to PP2A activity, GSK3β and Tau were found to be increased. In summary, our data reveal that sodium selenate enhances PP2A levels, but reduces catalytic activity of PP2A in a dose dependent manner, which fails to reduce Tau and GSK3β phosphorylation under physiological conditions, indicating an alternative route in the rescue of cell pathology in neurological disorders.</p><p> </p></div><h2>Other Information</h2> <p> Published in: International Journal of Molecular Sciences<br> License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/ijms20040844" target="_blank">https://dx.doi.org/10.3390/ijms20040844</a></p>2019-02-15T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/ijms20040844https://figshare.com/articles/journal_contribution/The_Anti-Tumor_Agent_Sodium_Selenate_Decreases_Methylated_PP2A_Increases_GSK3_Y216_Phosphorylation_Including_Tau_Disease_Epitopes_and_Reduces_Neuronal_Excitability_in_SHSY-5Y_Neurons/25428316CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/254283162019-02-15T03:00:00Z
spellingShingle The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
Wesal Habbab (17346961)
Chemical sciences
Analytical chemistry
Inorganic chemistry
Organic chemistry
Physical chemistry
Theoretical and computational chemistry
PP2A
GSK3β
Tau
retinoic acid differentiated SHSY-5Y cells
status_str publishedVersion
title The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
title_full The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
title_fullStr The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
title_full_unstemmed The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
title_short The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
title_sort The Anti-Tumor Agent Sodium Selenate Decreases Methylated PP2A, Increases GSK3βY216 Phosphorylation, Including Tau Disease Epitopes and Reduces Neuronal Excitability in SHSY-5Y Neurons
topic Chemical sciences
Analytical chemistry
Inorganic chemistry
Organic chemistry
Physical chemistry
Theoretical and computational chemistry
PP2A
GSK3β
Tau
retinoic acid differentiated SHSY-5Y cells